Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/200503 |
Resumo: | Piperazine designer drugs are a group of synthetic drugs of abuse that have appeared on the illicit market since the second half of the 1990s. The most common derivatives are 1-benzylpiperazine (BZP), 1-(4-methoxyphenyl)piperazine (MeOPP), and 1-(3,4-methylenedioxybenzyl)piperazine (MDBP). Generally, they can be consumed as capsules, tablets, but also in powder or liquid forms. Although less potent than amphetamines, piperazines have dopaminergic and serotonergic activities. The aim of this work was to evaluate the neurotoxic effects of BZP, MeOPP and MDBP using C. elegans as in vivo model through acute toxicity, development, reproduction, and behavior tests. The LD50 for BZP, MeOPP e MDBP was 52.21, 5.72, and 1.22 mM respectively. All concentrations were accompanied by a significant decrease in the body surface of the worms, indicating alteration of the development and decrease in reproduction. Worms exposed to piperazine designer drugs also presented a decrease in locomotor activity and mechanical sensitivity, suggesting the possible dysfunction of the nervous system. Neuronal damage was confirmed though the decrease in fluorescence of BY200 strains, indicating loss of dopaminergic transporters (DATs). In summary, we suggest that piperazine designer drugs leads to neuronal damage, which might be the underlying cause of altered behavior. |
id |
UFRGS-2_a9b959f2a935add01ad451370cdd5631 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/200503 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Souto, CarolineArbo, Marcelo DutraGöethel, Gabriela2019-10-11T03:54:04Z2017http://hdl.handle.net/10183/200503001052829Piperazine designer drugs are a group of synthetic drugs of abuse that have appeared on the illicit market since the second half of the 1990s. The most common derivatives are 1-benzylpiperazine (BZP), 1-(4-methoxyphenyl)piperazine (MeOPP), and 1-(3,4-methylenedioxybenzyl)piperazine (MDBP). Generally, they can be consumed as capsules, tablets, but also in powder or liquid forms. Although less potent than amphetamines, piperazines have dopaminergic and serotonergic activities. The aim of this work was to evaluate the neurotoxic effects of BZP, MeOPP and MDBP using C. elegans as in vivo model through acute toxicity, development, reproduction, and behavior tests. The LD50 for BZP, MeOPP e MDBP was 52.21, 5.72, and 1.22 mM respectively. All concentrations were accompanied by a significant decrease in the body surface of the worms, indicating alteration of the development and decrease in reproduction. Worms exposed to piperazine designer drugs also presented a decrease in locomotor activity and mechanical sensitivity, suggesting the possible dysfunction of the nervous system. Neuronal damage was confirmed though the decrease in fluorescence of BY200 strains, indicating loss of dopaminergic transporters (DATs). In summary, we suggest that piperazine designer drugs leads to neuronal damage, which might be the underlying cause of altered behavior.application/pdfengNeurotoxicidadeNeurotoxicityPiperazine designer drugsC. elegansPiperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegansinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal do Rio Grande do SulFaculdade de FarmáciaPorto Alegre, BR-RS2017Farmáciagraduaçãoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001052829.pdf.txt001052829.pdf.txtExtracted Texttext/plain41484http://www.lume.ufrgs.br/bitstream/10183/200503/2/001052829.pdf.txt14e944a2aba5bbb0b080893d0cb4c55cMD52ORIGINAL001052829.pdfTexto completo (inglês)application/pdf1539816http://www.lume.ufrgs.br/bitstream/10183/200503/1/001052829.pdf4ffca03391202feb2be8208d5bfc65d1MD5110183/2005032019-10-12 03:52:42.227631oai:www.lume.ufrgs.br:10183/200503Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2019-10-12T06:52:42Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
title |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
spellingShingle |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans Souto, Caroline Neurotoxicidade Neurotoxicity Piperazine designer drugs C. elegans |
title_short |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
title_full |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
title_fullStr |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
title_full_unstemmed |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
title_sort |
Piperazine designer drugs elicit neurotoxicity in the alternative in vivo model Caenorhabditis elegans |
author |
Souto, Caroline |
author_facet |
Souto, Caroline |
author_role |
author |
dc.contributor.author.fl_str_mv |
Souto, Caroline |
dc.contributor.advisor1.fl_str_mv |
Arbo, Marcelo Dutra |
dc.contributor.advisor-co1.fl_str_mv |
Göethel, Gabriela |
contributor_str_mv |
Arbo, Marcelo Dutra Göethel, Gabriela |
dc.subject.por.fl_str_mv |
Neurotoxicidade |
topic |
Neurotoxicidade Neurotoxicity Piperazine designer drugs C. elegans |
dc.subject.eng.fl_str_mv |
Neurotoxicity Piperazine designer drugs C. elegans |
description |
Piperazine designer drugs are a group of synthetic drugs of abuse that have appeared on the illicit market since the second half of the 1990s. The most common derivatives are 1-benzylpiperazine (BZP), 1-(4-methoxyphenyl)piperazine (MeOPP), and 1-(3,4-methylenedioxybenzyl)piperazine (MDBP). Generally, they can be consumed as capsules, tablets, but also in powder or liquid forms. Although less potent than amphetamines, piperazines have dopaminergic and serotonergic activities. The aim of this work was to evaluate the neurotoxic effects of BZP, MeOPP and MDBP using C. elegans as in vivo model through acute toxicity, development, reproduction, and behavior tests. The LD50 for BZP, MeOPP e MDBP was 52.21, 5.72, and 1.22 mM respectively. All concentrations were accompanied by a significant decrease in the body surface of the worms, indicating alteration of the development and decrease in reproduction. Worms exposed to piperazine designer drugs also presented a decrease in locomotor activity and mechanical sensitivity, suggesting the possible dysfunction of the nervous system. Neuronal damage was confirmed though the decrease in fluorescence of BY200 strains, indicating loss of dopaminergic transporters (DATs). In summary, we suggest that piperazine designer drugs leads to neuronal damage, which might be the underlying cause of altered behavior. |
publishDate |
2017 |
dc.date.issued.fl_str_mv |
2017 |
dc.date.accessioned.fl_str_mv |
2019-10-11T03:54:04Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/200503 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001052829 |
url |
http://hdl.handle.net/10183/200503 |
identifier_str_mv |
001052829 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/200503/2/001052829.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/200503/1/001052829.pdf |
bitstream.checksum.fl_str_mv |
14e944a2aba5bbb0b080893d0cb4c55c 4ffca03391202feb2be8208d5bfc65d1 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1801224584966438912 |